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Abstract
Bench-to-Bedside Diagnosis of Invasive Pulmonary Aspergillosis
Invasive pulmonary aspergillosis (IPA) is a life-threatening lung disease of haematological
malignancy and bone marrow transplant patients caused by the air-borne mould Aspergillus.
Current diagnostic tests for the disease lack sensitivity or specificity, and culture of the fungus
from invasive lung biopsy, considered the gold standard for IPA detection, is slow and often not
possible in critically ill patients. While Computed Tomography (CT) is a non-invasive diagnostic
procedure, it has limited clinical utility for IPA diagnosis, but is nevertheless used as a trigger for
commencing antifungal treatment in a number of centres.
Innovative approaches to the diagnosis of IPA are needed to enable diagnostic-driven treatment
with mould active drugs. In this talk, I will discuss the development of diagnostic technologies for
IPA detection based on the Aspergillus-specific mouse monoclonal antibody JF5, including the
CE-marked Aspergillus lateral-flow device (OLM Diagnostics), and CE-marked Aspergillus-ELISA
(Euroimmun AG). In addition, I will describe the humanisation of mAb JF5 for PET/MR imaging of
Aspergillus lung infections in vivo, and translation of the imaging technology to the clinical
setting.
I will finish by describing the recent development of a mAb, PD7, specific to A. fumigatus, and its
use to detect a novel protein biomarker of IPA in urine.
 
Print
